Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States

References

• Khavjou O, Phelps D, Leib A. Cardiovascular disease burden: a costly burden for America. Am Heart Assoc. 2016.
   Google Scholar
• Centers for Disease Control and Prevention. Heart Disease Facts. https://www.cdc.gov/heartdisease/facts.htm. Accessed 10 3, 2016.
   Google Scholar
• Centers for Disease Control and Prevention. High Cholesterol in the United States. http://www.cdc.gov/cholesterol/facts.htm. Accessed 103, 2016.
   Google Scholar
• Baigent C, Keech A, Kearney PM, et al.; Cholesterol Treatment Trialists (CCT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–1278. doi:10.1016/S0140-6736(05)67394-116214597
   PubMed Web of Science ®Google Scholar
• Consumer Reports. Best Buy Drugs: Evaluating Statin Drugs to Treat High Cholesterol and Heart Disease. New York, NY: Consumer Reports;2014.
   Google Scholar
• Lin I, Sung J, Sanchez RJ, et al. Patterns of statin use in a real-world population of patients at high cardiovascular risk. J Manag Care Spec Pharm. 2016;22(6):685–698. doi:10.18553/jmcp.2016.22.6.68527231796
   PubMedGoogle Scholar
• Newby LK, Lapoint NMA, Chen AY, et al. Long-term adherence to evidence based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203–212. doi:10.1161/CIRCULATIONAHA.105.50563616401776
   PubMed Web of Science ®Google Scholar
• Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC, Schrank W. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008;17(12):1189–1196. doi:10.1002/pds.167118956426
   PubMed Web of Science ®Google Scholar
• Lemstra M, Blackburn D. Nonadherence to statin therapy: discontinuation after a single fill. Can J Cardiol. 2012;28:567–573. doi:10.1016/j.cjca.2012.03.01822658124
   PubMed Web of Science ®Google Scholar
• Brookheart AM, Patrick AR, Schneeweiss S, et al. Physician follow-up and provider continuity are associated with long-term medication adherence. Arch Intern Med. 2007;167:847–852. doi:10.1001/archinte.167.8.84717452550
   PubMedGoogle Scholar
• Pittman DG, Chen W, Bowlin SJ, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107(11):1662–1666. doi:10.1016/j.amjcard.2011.01.05221439533
   PubMed Web of Science ®Google Scholar
• Bijlsma M, Vansteelandt S, Janssen F, Hak E. The effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-points. BMC Public Health. 2016;16:303. doi:10.1186/s12889-016-2986-027067123
   PubMed Web of Science ®Google Scholar
• Haukka J, Niskanen L, Partonen T, Lonnqvist J, Tiihonen J. Statin usage and all-cause and disease-specific mortality in a nationwide study. Pharmacoepidemiol Drug Saf. 2012;21:61–69. doi:10.1002/pds.225521956915
   PubMed Web of Science ®Google Scholar
• Wei L, Fahey T, MacDonald TM. Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behavior vs. drug effects and 10-year follow-up of outcome. Br J Clin Pharmacol. 2008;66(1):110–116. doi:10.1111/j.1365-2125.2008.03212.x18492127
   PubMed Web of Science ®Google Scholar
• De Vera M, Bhole V, Burns LC, Lacaille D. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol. 2014;78(4):684–698. doi:10.1111/bcp.1233925364801
   PubMed Web of Science ®Google Scholar
• Hamood H, Hamood R, Green MS, Almog R. Effect of adherence to evidence-based therapy after acute myocardial infarction on all-cause mortality. Pharmacoepidemiol Drug Saf. 2015;24:1093–1104. doi:10.1002/pds.384026183333
   PubMed Web of Science ®Google Scholar
• Chen PS, Cheng CL, Yang YH, Li YH. Statin adherence after ischemic stroke or transient ischemic attack is associated with clinical outcome. Circ J. 2016;80:731–737. doi:10.1253/circj.CJ-15-075326742588
   PubMed Web of Science ®Google Scholar
• Herttua K, Martikainen P, Batty GD, Kivimaki M. Poor adherence to statin and antihypertensive therapies as risk factors for fatal stroke. J Am Coll Cardiol. 2016;67(13):1507–1515. doi:10.1016/j.jacc.2016.01.04427150680
   PubMed Web of Science ®Google Scholar
• Ho PM, Magid DJ, Shetterly SM, et al. Medication non-adherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772–779. doi:10.1016/j.ahj.2007.12.01118371492
   PubMed Web of Science ®Google Scholar
• Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–186. doi:10.1001/jama.297.2.17717213401
   PubMed Web of Science ®Google Scholar
• Poluzzi E, Piccinni C, Carta P, et al. Cardiovascular events in statin recipients: impact of adherenc to treatment in a 3-year record linkage study. Eur J Clin Pharmacol. 2011;67:407–414. doi:10.1007/s00228-010-0958-321152908
   PubMed Web of Science ®Google Scholar
• Siebert W, Alagoz O, Bayloumi AM, et al. State-transition modelling: a report of the ISPOR-SMDM modelling good research practices task force-3. Value Health. 2012;15:812–820. doi:10.1016/j.jval.2012.06.01422999130
   PubMed Web of Science ®Google Scholar
• National Inpatient Sample 2014. Healthcare cost and utilization project. https://hcupnet-archive.ahrq.gov/. Accessed 512, 2017.
   Google Scholar
• D’Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J. 2000;139(2):272–281. doi:10.1067/mhj.2000.9646910650300
   PubMed Web of Science ®Google Scholar
• Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term risk of first recurrent stroke in the Perth community stroke study. Stroke. 1998;29:2491–2500.9836757
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk condition. Lancet. 2004;363:757–767. doi:10.1016/S0140-6736(04)15690-015016485
   PubMed Web of Science ®Google Scholar
• The Long-term Intervention with Pravastatin in ischaemic disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339(19):1349–1357. doi:10.1056/NEJM1998110533919029841303
   PubMed Web of Science ®Google Scholar
• Rublee DA, Chen SY, Mardekian J, Wu N, Rao P, Boulanger L. Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy. Am J Ther. 2012;19:24–32. doi:10.1097/MJT.0b013e3181ee707e20838204
   PubMed Web of Science ®Google Scholar
• Arias E, Heron M, Xu J. National vital statistics reports, United States life tables 2012. Natl Health Stat. 2016;65(8):1-65.
   Google Scholar
• Vupputuri S, Joski P, Kilpatrick R, et al. LDL cholesterol response and statin adherence among high-risk patients initiating treatment. Am J Manag Care. 2016;22(3):e106–e115.26978237
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410–420. doi:10.1177/0272989X0629049516855129
   PubMed Web of Science ®Google Scholar
• Arrieta A, Page TF, Veledar E, Nasir K. Economic evaluation of PCSK9 inhibitors in reducing cardiovascular risk from health system and private payer perspectives. PLOSone. 2017;12:e0169761. doi:10.1371/journal.pone.0169761
   PubMed Web of Science ®Google Scholar
• Shiffman, D, Arellano AR, Caulfield MP, et al. Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost effectiveness analysis. BMC Cardiovasc Disord. 2016;16:251. doi:10.1186/s12872-016-0371-727927162
   PubMed Web of Science ®Google Scholar
• National Inpatient Sample 2014. Healthcare cost and utilization project. https://hcupnet-archive.ahrq.gov/. Accessed 330, 2017.
   Google Scholar
• Chapman RH, Ferrufino CP, Kowal SL, Classi P, Roberts CS. The costs and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs. Int J Clin Pract. 2010;64(2):169–181. doi:10.1111/j.1742-1241.2009.02196.x20089007
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Current procedure terminology, physician fee schedule. https://www.cms.gov/apps/physician-fee-schedule/license-agreement.aspx, Accessed 717, 2017.
   Google Scholar
• Medi-Span Price Rx Database. http://www.wolterskluwercdi.com/price-rx/. Accessed 512, 2017.
   Google Scholar
• Erickson KF, Japa S, Owens DK, et al. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013;61(12):1250–1258. doi:10.1016/j.jacc.2012.12.03423500327
   PubMed Web of Science ®Google Scholar
• Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR. Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost effectiveness in health and medicine. Pharmacoeconomics. 1997;11(2):159–168. doi:10.2165/00019053-199711020-0000510172935
   PubMed Web of Science ®Google Scholar
• Coberly C, Morrow G, McGinnis M, et al. Increased adherence to cardiac standards of care during participation in cardiac disease management programs. Dis Manage. 2008;11(2):111–118. doi:10.1089/dis.2008.112725
   Google Scholar
• Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, LaPoint NM. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomised trial. Am Heart J. 2012;163(657–665.e1). doi:10.1016/j.ahj.2012.02.010
   Web of Science ®Google Scholar
• Damush TM, Myers L, Anderson JA, et al. The effect of a locally adapted, secondary stroke risk factor self-management program on medication adherence among veterans with stroke/TIA. Transl Behav Med. 2016;6:457–468.27349906
   PubMed Web of Science ®Google Scholar
• Harbman P. The development and testing of a nurse practitioner secondary prevention intervention for patients after acute myocardial infarction: a prospective cohort study. Int J Nurs Stud. 2014;51:1542–1568. doi:10.1016/j.ijnurstu.2014.04.00424836930
   PubMed Web of Science ®Google Scholar
• Ma Y, Ockene IS, Rosal MC, Merriam PA, Ockene JK, Gandhi PJ. Randomised trial of a pharmacist-delivered intervention for improving lipid-lowering medication adherence among patients with coronary heart disease. Cholesterol. 2010;383281. doi:10.1155/2010/38328121490915
   PubMedGoogle Scholar
• Jelinek M, Vale MJ, Liew D, et al. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications – two years follow-up. Heart Lung Circ. 2009;18:388–392. doi:10.1016/j.hlc.2009.06.00119648058
   PubMed Web of Science ®Google Scholar
• Park LG, Howie-Esquivel J, Chung ML, Dracup K. The test messaging intervention to promote medication adherence for patients with coronary heart disease: a randomised controlled trial. Patient Educ Couns. 2014;94:261–268. doi:10.1016/j.pec.2013.10.02724321403
   PubMed Web of Science ®Google Scholar
• Reddy A, Huseman TL, Canamucio A. Patient and partner feedback reports to improve statin medication adherence: a randomised control trial. J Gen Intern Med. 2016;32(3):256–261. doi:10.1007/s11606-016-3858-027612487
   PubMed Web of Science ®Google Scholar
• Vollmer WM, Owen-Smith AA, Tom JO. Improving adherence to cardiovascular disease medications with information technology. Am J Manag Care. 2014;20(11):SP502–SP510.25811824
   PubMed Web of Science ®Google Scholar
• Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Providing systematic detailed information on medication upon hospital discharge as an important step towards improved transitional care. J Clin Ther. 2014;39:286–291.
   Web of Science ®Google Scholar
• Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Adherence to hospital discharge medication in patients with ischemic stroke: a prospective, interventional 2-phase study. Stroke. 2013;44:522–524. doi:10.1161/STROKEAHA.112.67884723223505
   PubMed Web of Science ®Google Scholar
• Van Driel ML, Morledge MD, Ulep R, Shaffer JP, Davies P, Deichmann R. Interventions to improve adherence to lipid-lowering medication (Review). Cochrane Database Syst Rev. 2016;12. doi:10.1002/14651858.CD003091.pub4
   Web of Science ®Google Scholar
• Jörntѐn-Karlsson M, Pintat S, Molloy-Bland M, Berg S, Ahlqvist M. Patient-centered interventions to improve adherence to statins: a narrative synthesis of systematically identified studies. Drugs. 2016;76:1447–1465. doi:10.1007/s40265-016-0640-x27677773
   PubMed Web of Science ®Google Scholar
• Smith DH, O’Keefe-Rosetti M, Owen-Smith AA, et al. Improving adherence to cardiovascular therapies: an economic evaluation of a randomized pragmatic trial. Value Health. 2016;19(2):176–184. doi:10.1016/j.jval.2015.11.01327021751
   PubMed Web of Science ®Google Scholar
• Vegter S, Oosterhof P, van Boven JFM, Stuurman-Bieze AGG, Hiddink EG, Postma MJ. Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis. J Manag Care Pharm. 2014;20(7):722–732.
   PubMed Web of Science ®Google Scholar
• Stuurman-Bieze AG, Hiddink EG, van Boven JF, Vegter S. Proactive pharmaceutical care interventions improve patients’ adherence to lipid lowering medication. Ann Pharmacother. 2013;47(11):1448–1456. doi:10.1177/106002801350114624259595
   PubMed Web of Science ®Google Scholar
• Ford I, Murray H, McCowan C, Packard CJ. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study. Circulation. 2016;133(11):1073–1080. doi:10.1161/CIRCULATIONAHA.115.01901426864092
   PubMed Web of Science ®Google Scholar